Medical Device News Magazine

World’s 1st Total Knee Replacement Patient Treated with PolarisAR Breakthrough Mixed-Reality Surgical Guidance System

STELLAR Knee ushers in a new era of mixed-reality total joint arthroplasty

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

PolarisAR

PolarisAR, a developer of advanced mixed-reality surgical guidance technology, announced the first total knee arthroplasty (TKA) using its STELLAR Knee mixed-reality surgical guidance system.

The procedure was performed at New York-Presbyterian/Columbia University Irving Medical Center in New York.

STELLAR Knee

STELLAR Knee is a mixed-reality surgical navigation platform that guides TKA procedures by displaying measured and computed data overlaid directly in a 3D environment. The mixed-reality system acts as a spatial computer, creating continuous data exchange between the surgeon and the software to help enhance surgical decision-making while simplifying operating room workflow.

Paul Mikus, CEO of PolarisAR

“STELLAR Knee represents a paradigm shift in the OR, as we aim to offer surgeons robot-like precision and real-time guidance throughout TKA procedures. STELLAR Knee also fills a crucial gap in hospitals where existing robotic systems may already be in use. By seamlessly integrating into surgical workflows and delivering comparable precision in a mixed reality format, STELLAR Knee ensures that every patient can now access the highest standard of care.”

FDA

The U.S. Food & Drug Administration (FDA) cleared the STELLAR Knee mixed-reality surgical guidance system in November 2023 for use in TKA procedures.

The STELLAR Knee system is designed to offer precise control over intraoperative variables compared to traditional instruments, navigation systems, and first-generation augmented reality. Through meticulous measurement, planning and guidance, it enables surgeons to optimize lower limb alignment, soft tissue balance, joint line maintenance and component positioning.

Over the next coming several weeks, STELLAR Knee’s commercial launch will continue at leading institutions throughout the U.S.

Traditional Techniques for TKA

Traditional techniques for TKA have long been associated with various challenges and limitations. Surgeons often face difficulties in achieving precise alignment and balance of the lower limb. Additionally, closed implant systems and preoperative imaging methods may restrict flexibility and customization, limiting the surgeon’s ability to tailor the procedure to individual patient needs. In addition, traditional robotic technologies, with their large intraoperative footprint, can present barriers to widespread adoption. By contrast, Stellar Knee is agnostic to implant and imageless, making it more accessible to surgeons. The democratization of enabling technologies is a key objective for PolarisAR.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”